Fundraising FoxCadence Healthcare Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)in
Board seatChristopher Kaster· per SEC Form D · $91.4M raise · filed Jan 2025
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundGilde HealthcareGilmartin Capital LLCOmega Funds+2 more
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)in
BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in
Co-investorsAphelion CapitalShangBay Capital LLCCatalyst Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.